985062

Xttrium Laboratories, Inc. — FEI 3008436464

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 25, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Mount Prospect, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)